ProfileGDS5822 / ILMN_2855792
TitleAnti-CTLA-4 immunotherapy effect on αSMA+ myofibroblast late-depleted pancreatic ductal adenocarcinoma model
OrganismMus musculus


control myofibroblast depletion untreated anti-CTLA4 antibody GSM1276599 GSM1276600 GSM1276601 GSM1276602 GSM1276603 GSM1276604 GSM1303940 GSM1303941 GSM1303942 84% 90% 88% 86% 87% 84% 87% 88% 88% sort by protocol sort by agent Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM1276599PDAC Late Ablation Control 122184
GSM1276600PDAC Late Ablation Control 247990
GSM1276601PDAC Late Ablation Control 3465.588
GSM1276602PDAC Late Ablation 1283.286
GSM1276603PDAC Late Ablation 2328.387
GSM1276604PDAC Late Ablation 3261.284
GSM1303940PDAC Late Ablation_anti-CTLA4 1331.387
GSM1303941PDAC Late Ablation_anti-CTLA4 2463.488
GSM1303942PDAC Late Ablation_anti-CTLA4 3450.388